K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 125 JPY 0.98% Market Closed
Market Cap: 156.2B JPY

Intrinsic Value

The intrinsic value of one Kaken Pharmaceutical Co Ltd stock under the Base Case scenario is hidden JPY. Compared to the current market price of 4 125 JPY, Kaken Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Kaken Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Kaken Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Kaken Pharmaceutical Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Kaken Pharmaceutical Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Kaken Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Kaken Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Kaken Pharmaceutical Co Ltd.

Explain Valuation
Compare Kaken Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Kaken Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Kaken Pharmaceutical Co Ltd

Current Assets 98.8B
Cash & Short-Term Investments 57.1B
Receivables 21.8B
Other Current Assets 19.9B
Non-Current Assets 78.5B
Long-Term Investments 17.9B
PP&E 28.6B
Intangibles 18.8B
Other Non-Current Assets 13.2B
Current Liabilities 22.4B
Accounts Payable 5.9B
Accrued Liabilities 927m
Short-Term Debt 3.9B
Other Current Liabilities 11.7B
Non-Current Liabilities 7B
Other Non-Current Liabilities 7B
Efficiency

Free Cash Flow Analysis
Kaken Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kaken Pharmaceutical Co Ltd

Revenue
82B JPY
Cost of Revenue
-36B JPY
Gross Profit
46B JPY
Operating Expenses
-44.4B JPY
Operating Income
1.7B JPY
Other Expenses
-1B JPY
Net Income
651m JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Kaken Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Gross Margin is Increasing
hidden
Profitability
Score

Kaken Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Kaken Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Kaken Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Kaken Pharmaceutical Co Ltd

Wall Street analysts forecast Kaken Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Kaken Pharmaceutical Co Ltd is 4 590 JPY with a low forecast of 3 636 JPY and a high forecast of 5 670 JPY.

Lowest
Price Target
3 636 JPY
12% Downside
Average
Price Target
4 590 JPY
11% Upside
Highest
Price Target
5 670 JPY
37% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Kaken Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Kaken Pharmaceutical Co Ltd stock?

The intrinsic value of one Kaken Pharmaceutical Co Ltd stock under the Base Case scenario is hidden JPY.

Is Kaken Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 4 125 JPY, Kaken Pharmaceutical Co Ltd is hidden .

Back to Top